Clinical Trials Directory

Trials / Completed

CompletedNCT02782455

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease a Randomised Triple Blind Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Services Hospital, Lahore · Other Government
Sex
All
Age
13 Years – 80 Years
Healthy volunteers
Accepted

Summary

Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When inflamed they become pathological and may present with protrusion and bleeding. A randomized, triple blind , controlled study will be conducted to compare the efficacy of calcium dobesilate against flavanoids in the management of early haemorrhoidal disease.

Conditions

Interventions

TypeNameDescription
DRUGFlavonoidsDaflon is administered
DRUGCDobiCalcium dobesylate is administered

Timeline

Start date
2016-12-01
Primary completion
2018-11-30
Completion
2018-11-30
First posted
2016-05-25
Last updated
2018-12-26

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT02782455. Inclusion in this directory is not an endorsement.

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease (NCT02782455) · Clinical Trials Directory